Episodes
Tuesday Sep 28, 2021
30: Community Involvement with Pharm A Save Monroe Pharmacy
Tuesday Sep 28, 2021
Tuesday Sep 28, 2021
Being thrown into the pandemic has shown us that not only is every independent pharmacy a hero, but that some should wear capes! To celebrate National Good Neighbor Day, which is celebrated annually on September 28, one of our Good Neighbor Pharmacy stores details how they stay involved in the community and practice being a good neighbor every day to the patients they serve. This pharmacy exemplifies how our industry has risen to the challenge of being a trusted member of the communities they serve.
Join new host, Justin Baker, a Business Coach for AmerisourceBergen, as he celebrates the extraordinary community involvement of Pharm A Save Monroe Pharmacy in Washington state, with its owner, Bridgett Edgar.
To stay connected with and give back to her community, Bridgett personifies her “all in this together” mantra to highlight her initiatives like fundraising partnerships with local health systems, patient charity events, her Free Vitamin Program with the local schools, and local National Night Out Against Crime involvement. Bridgett’s energy is contagious as she shares her tricks and tips on how to “pick your passion,” get started and get involved
Wednesday Sep 01, 2021
29: SPECIAL EDITION: Insulin Biosimilars Part 1
Wednesday Sep 01, 2021
Wednesday Sep 01, 2021
This special edition episode is brought to you by AmerisourceBergen’s Insights podcast. In part one of a two-part series on insulin biosimilars, host, Jennifer Kemper, Director of Content Strategy, speaks with Sean McGowan, Senior Director of Biosimilars, Michelle Jesse, Director of Biosimilar Commercialization, and Brad Tallamy, Senior Director of Government Affairs, about what these new drugs could mean for the category. They’ll discuss how and why insulins are in the biosimilar category, how congress is approaching biosimilars, and if an interchangeability status is on the horizon.
Be on the lookout for part two! Our host and guests stay on the topic of insulin biosimilars and discuss how pharmacies can prepare for interchangeability.